Buscar
-
Ophthalmologic Phenotype-Genotype Correlations in Patients With Oculocutaneous Albinism Followed in a Reference Center
(Investigative Ophthalmology & Visual Science. vol. 64, n° 12, pp. 26, 2023-09-01)Article de revueLibre acceso -
Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory
(Diabetes and Metabolism. vol. 47, n° 1, pp. 101156, 2021-02)Article de revueLibre acceso -
Predicting the retinal content in omega-3 fatty acids for age-related macular-degeneration
(Clinical and Translational Medicine. vol. 11, n° 7, pp. e404, 2021-07)Article de revueLibre acceso -
Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis
(Journal of Clinical Medicine. vol. 11, n° 7, 2022-03-25)Article de revueLibre acceso -
Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims data
(Journal of Medical Economics. vol. 24, n° 1, pp. 1-37, 2021-08-23)Article de revueLibre acceso -
Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus
(Current Opinion in Ophthalmology. vol. 34, n° 5, pp. 403-413, 2023-09-01)Article de revueLibre acceso -
TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration
(Ophthalmology Science. vol. 1, n° 4, 2021-12)Article de revueLibre acceso -
Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials
(Ophthalmology: Journal of The American Academy of Ophthalmology, 2023-12-27)Article de revueLibre acceso -
The impact of artificial intelligence on retinal disease management: Vision Academy retinal expert consensus
(Current Opinion in Ophthalmology. vol. 34, n° 5, pp. 396-402, 2023-09-01)Article de revueLibre acceso -
Microperimetry to predict disease progression in eyes at high risk of age-related macular degeneration disease: The PREVISION study
(Acta Ophthalmologica. vol. 101, n° 2, pp. e135-e142, 2023-03)Article de revueLibre acceso